Kristine Mørch
Position
Associate Professor, Head National Center for Tropical Infectious Diseases, Haukeland University Hospital
Affiliation
Research
Kristine Mørch, MD, PhD, is head of National Center for Tropical Infectious Diseases at Infectious Diseases Section, Department of Medicine, Haukeland university hospital. She is also associate professor at Department of Clinical Science, University of Bergen. Her main research interest is the field of tropical infectious diseases, particularly acute febrile diseases and malaria, as well as giardiasis with focus on resistance and treatment of metronidazol refractory infections.
Publications
Academic article
- Blomberg, Bjørn; Bruun, Trond; Jordal, Stina et al. (2024). Ein mann i 60-åra med livstrugande febersjukdom etter utanlandsreise. (external link)
- Onken, Annette; Moyo, Sabrina John; Miraji, Mohammed Khamis et al. (2024). Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar. (external link)
- Jensenius, Mogens; Mørch, Kristine; Yakub, Sheraz et al. (2024). Alveolær ekinokokkose. (external link)
- Hoem, Eli Leirdal; Kvalvik, Torleiv; Dyrhovden, Ruben et al. (2024). En kvinne i 70-årenemed feber og krampeanfall. (external link)
- Mørch, Kristine; Manoharan, Anand; Chandy, Sara et al. (2023). Clinical features and risk factors for death in acute undifferentiated fever: A prospective observational study in rural community hospitals in six states of India. (external link)
- Onken, Annette; Haanshuus, Christel Gill; Miraji, Mohammed Khamis et al. (2022). Malaria prevalence and performance of diagnostic tests among patients hospitalized with acute undifferentiated fever in Zanzibar. (external link)
- Hanevik, Kurt; Saghaug, Christina Skår; Aaland, Maren et al. (2022). No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection. (external link)
- Muller, Karl Erik; Blomberg, Bjørn; Tellevik, Marit Gjerde et al. (2021). Leishmaniasis i Norge. (external link)
- Kristiansen, Trygve; Pettersen, Frank O.; Lier, Tore et al. (2021). Schistosomiasis hos norske studenter etter opphold i Afrika. (external link)
- Neumayr, Andreas; Schunk, Mirjam; Theunissen, Caroline et al. (2021). Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study. (external link)
- Emberland, Knut Erik; Wensaas, Knut-Arne; Litleskare, Sverre et al. (2021). Antibiotics for gastroenteritis in general practice and out-of-hours services in Norway 2006-15. (external link)
- Waldenström, Jesper; Hellstrand, Kristoffer; Westin, Johan et al. (2021). Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus. (external link)
- Haanshuus, Christel Gill; Mørch, Kristine (2020). Detection of remaining Plasmodium DNA and gametocytes during follow up after curative malaria treatment among returned travellers in Norway. (external link)
- Waldenström, Jesper; Nyström, Kristina; Nilsson, Staffan et al. (2020). The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection. (external link)
- Moyo, Sabrina John; Manyahi, Joel; Blomberg, Bjørn et al. (2020). Bacteraemia, malaria, and case fatality among children hospitalized with fever in Dar es Salaam, Tanzania. (external link)
- Mørch, Kristine; Hanevik, Kurt (2020). Giardiasis treatment: an update with a focus on refractory disease. (external link)
- Blomberg, Bjørn; Muller, Karl Erik; Helgeland, Lars et al. (2019). En mann i 80-årene med leddgikt og vedvarende feber. (external link)
- Haanshuus, Christel Gill; Mørch, Kristine; Blomberg, Bjørn et al. (2019). Assessment of malaria real-time PCR methods and application with focus on lowlevel parasitaemia. (external link)
- Kurth, Florian; Develoux, Michel; Mechain, Matthieu et al. (2017). Severe malaria in Europe: an 8-year multi-centre observational study. (external link)
- Mørch, Kristine; Manoharan, Anand; Chandy, Sara et al. (2017). Acute undifferentiated fever in India: A multicentre study of aetiology and diagnostic accuracy. (external link)
- Lingscheid, Tilman; Kurth, Florian; Clerinx, Jan et al. (2017). Schistosomiasis in european travelers and migrants: Analysis of 14 years tropnet surveillance data. (external link)
- Hanevik, Kurt; Kristoffersen, Einar Klæboe; Mørch, Kristine et al. (2017). Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome. (external link)
- Chandy, Sara; Kirubanandhan, Lokeshwaran; Hemavathy, Priya et al. (2017). Serovar prevalence of leptospira in semirural India and the development of an igm-based indirect ELISA. (external link)
- Wensaas, Knut-Arne; Hanevik, Kurt; Hausken, Trygve et al. (2016). Postinfectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap: results from a controlled cohort study 3 years after acute giardiasis. (external link)
- Waldenström, Jesper; Färkkilä, Martti A.; Rembeck, Karolina et al. (2016). Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience. (external link)
- Haanshuus, Christel Gill; Chandy, Sara; Manoharan, Anand et al. (2016). A high malaria prevalence identified by PCR among patients with acute undifferentiated fever in India. (external link)
- Heggheim, Åsmund; Blomberg, Bjørn; Mørch, Kristine (2015). Beredskap ved alvorlig malaria. (external link)
- Ben-Chetrit, Eli; Lachish, Tamar; Mørch, Kristine et al. (2015). Schistosomiasis in pregnant travelers: A case series. (external link)
- Kurth, Florian; Develoux, Michel; Mechain, Matthieu et al. (2015). Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: The TropNet severe malaria study. (external link)
- Ydreborg, Magdalena; Lisovskaja, Vera; Lagging, Martin et al. (2014). A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. (external link)
- Hanevik, Kurt; Wensaas, Knut-Arne; Rørtveit, Guri et al. (2014). Irritable bowel syndrome and chronic fatigue 6 years after Giardia infection: A controlled prospective cohort study. (external link)
- Rembeck, Karolina; Waldenström, Jesper; Hellstrand, Kristoffer et al. (2014). Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. (external link)
- Abrahamsen, Siri Kratter; Haugen, Cathrine Ingebjørg Nødtvedt; Rupali, Priscilla et al. (2013). Fever in the tropics: aetiology and case-fatality - a prospective observational study in a tertiary care hospital in South India. (external link)
- Haanshuus, Christel Gill; Mohn, Stein Christian; Mørch, Kristine et al. (2013). A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway. (external link)
- Mørch, Kristine; Hanevik, Kurt; Rivenes, Ann Christin et al. (2013). Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. (external link)
- Alsiö, Åsa; Rembeck, Karolina; Askarieh, Galia et al. (2012). Impact of Obesity on the Bioavailability of Peginterferon-alpha 2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3. (external link)
- Alsiö, Åsa; Jannesson, Anna-Maria; Langeland, Nina et al. (2012). Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection. (external link)
- Hunskår, Gunnhild Sellevoll; Langeland, Nina; Wensaas, Knut-Arne et al. (2012). The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study. (external link)
- Rembeck, Karolina; Alsiö, Åsa; Christensen, Peer Brehm et al. (2012). Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. (external link)
- Hanevik, Kurt; Kristoffersen, Einar Klæboe; Sørnes, Steinar et al. (2012). Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome. (external link)
- Rembeck, Karolina; Maglio, Cristina; Lagging, Martin et al. (2012). PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection. (external link)
- Wensaas, Knut-Arne; Langeland, Nina; Hanevik, Kurt et al. (2012). Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. (external link)
- Pedersen, Court; Alsiö, Åsa; Lagging, Martin et al. (2011). Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection. (external link)
- Lindh, Maria; Eilard, Anders; Färkkilä, Martti et al. (2011). Hepatitis C treatment response kinetics and impact of baseline predictors. (external link)
- Lindh, Magnus; Lagging, Martin; Färkkilä, Martti et al. (2011). Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus. (external link)
- Zoller, Thomas; Junghanss, Thomas; Kapaun, Annette et al. (2011). Intravenous Artesunate for Severe Malaria in Travelers, Europe. (external link)
- Alsiö, Åsa; Christensen, Peer Brehm; Färkkilä, Martti et al. (2010). Nonresponder Patients with Hepatitis C Virus Genotype 2/3 Infection: A Question of Low Systemic Interferon Concentrations?. (external link)
- Leutscher, Peter Derek Christian; Lagging, Martin; Buhl, Mads Rauning et al. (2010). Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. (external link)
- Robertson, Lucy J; Hanevik, K; Escobedo, Angel A et al. (2010). Giardiasis ? why do the symptoms sometimes never stop?. (external link)
- Escobedo, Angel A; Almirall, P; Robertson, Lucy J et al. (2010). Giardiasis: the ever-present threat of a neglected disease. (external link)
- Mørch, Kristine; Hanevik, Kurt; Rørtveit, Guri et al. (2009). High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis. (external link)
- Mørch, Kristine; Hanevik, Kurt; Rørtveit, Guri et al. (2009). Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. (external link)
- Hanevik, Kurt; Mørch, Kristine; Eide, Geir Egil et al. (2008). Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: A randomized open clinical trial. (external link)
- Mørch, Kristine; Hanevik, Kurt; Robertson, Lucy J. et al. (2008). Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. (external link)
- Strand, Elisabeth Astrup; Robertson, Lucy J.; Hanevik, Kurt et al. (2008). Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. (external link)
- Lagging, Martin; Langeland, Nina; Pedersen, Court et al. (2008). Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection. (external link)
Doctoral dissertation
Short communication
Reader opinion piece
- Robertson, Lucy; Tysnes, Kristoffer; Hanevik, Kurt et al. (2015). Hund som Giardia-kilde i Bergen i 2004 - barking up the wrong tree?. (external link)
- Lagging, Martin; Alsiö, Åsa; Langeland, Nina et al. (2011). Early determination of Hepatitis C virus RNA may help to decide the duration of therapy for chronic Hepatitis C virus genotype 2/3 infection. (external link)
- Lagging, Martin; Langeland, Nina; Pedersen, Court et al. (2008). Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection. (external link)
Feature article
Abstract
- Rembeck, Karolina; Lindh, Magnus; Pedersen, Court et al. (2012). Impact of Inosine Triphosphatase (ITPA) Gene Variants on Anemia, Ribavirin Concentrations, and Outcome During Therapy for HCV Genotype 2/3. (external link)
- Ydreborg, Magdalena; Lagging, Martin; Norkrans, Gunnar P. et al. (2012). A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. (external link)
- Rembeck, Karolina; Alsio, Asa; Christensen, Peer B. et al. (2011). Impact of obesity on the bioavailability of peginterferon-alpha 2A and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3. (external link)
- Alsio, Asa; Langeland, Nina; Pedersen, Court et al. (2010). IMPORTANCE OF HCV CORE ANTIGEN BELOW 0.2 PG/ML DAY 3 IN SHORT-TERM PEG-INTERFERON THERAPY FOR CHRONIC GENOTYPE2/3 INFECTION. (external link)
- Leutscher, Peter Derek Christian; Buhl, Mads Rauning; Lagging, Martin et al. (2009). EVALUATION OF THE ROUTINE MEDICAL INTERVIEW TO IDENTIFY HEPATITIS C PATIENTS DEVELOPING MAJOR DEPRESSION DURING PEGINTERFERON ALFA-2A PLUS RIBAVIRIN TREATMENT USING THE MAJOR DEPRESSION INVENTORY. (external link)
- Westin, Johan; Lagging, Martin; Pedersen, Carsten et al. (2008). Twelve weeks of treatment is insufficient for HCV genotype 2 and 3 infected patients with steatosis. (external link)
- Christensen, Peer B.; Alsiö, Åsa; Buhl, Mads Rauning et al. (2008). Ribavirin concentration at week four is an independend predictor for sustained virological response after treatment of hepatitis C genotype 2/3 (NORDynamic trial). (external link)
- Lagging, Martin; Pedersen, Court; Buhl, Mads Rauning et al. (2007). Peginterferon alfa-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2/3: The nordynamic trial. (external link)
- Lagging, Martin; Pedersen, Carsten; Buhl, Mads Rauning et al. (2007). Comparison of peginterferon alpha-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2/3: The nordynamic trial. (external link)